Titre :
  • An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
Auteur : Viscoli, Claudio ; Herbrecht, R ; Akan, Hamdi ; Baila, L. ; Sonet, Alexis ; Gallamini, A ; Giagounidis, A ; Marchetti, Oscar ; Martino, Robert ; Meert, L ; Paesmans, Marianne ; Ameye, Lieveke ; Shivaprakash, M ; Ullmann, Andrew ; Maertens, J. ; Infectious Disease Group of the EORTC
Informations sur la publication : Journal of antimicrobial chemotherapy, 64, 6, (page 1274-1281)
Statut de publication : Publié, 2009-12
Sujet CREF : Cancérologie
Mots-clés : Acute leukaemia
Echinocandins
Fungal infections
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antifungal Agents -- administration & dosage -- therapeutic use
Aspergillosis -- drug therapy
Echinocandins -- administration & dosage -- therapeutic use
Female
Hematologic Neoplasms -- complications
Humans
Male
Middle Aged
Survival Analysis
Transplantation, Autologous -- adverse effects
Treatment Outcome
Young Adult
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0305-7453 
info:doi/10.1093/jac/dkp355
info:pii/dkp355
info:pmid/19841031